4//SEC Filing
MACKENZIE GREGORY SCOTT 4
Accession 0001181431-06-002687
CIK 0000070033other
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 9:26 AM ET
Size
7.7 KB
Accession
0001181431-06-002687
Insider Transaction Report
Form 4
MACKENZIE GREGORY SCOTT
EVP & GM-Pharmacy
Transactions
- Disposition to Issuer
Common Stock
2006-01-06−17,000→ 0 total - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2006-01-06−50,000→ 0 total→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]Each share of issuer common stock was disposed of pursuant to the merger agreement between the issuer and Per-Se Technologies, Inc. ("Per-Se") in exchange for the merger consideration, which consists of (i) $14.05 in cash, plus (ii) a number of shares of Per-Se common stock equal to $5.45 divided by $24.188 (the "Merger Consideration").
- [F2]The reporting person held an aggregate of 50,000 options, which had various exercise prices, vesting schedules and expiration dates. Each of these options was cancelled pursuant to the merger agreement between the issuer and Per-Se in exchange for a payment of cash and shares of Per-Se common stock representing the difference between the Merger Consideration and the exercise price of the option.
Documents
Issuer
NDCHEALTH CORP
CIK 0000070033
Entity typeother
Related Parties
1- filerCIK 0001317743
Filing Metadata
- Form type
- 4
- Filed
- Jan 9, 7:00 PM ET
- Accepted
- Jan 10, 9:26 AM ET
- Size
- 7.7 KB